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Viruses can spread by different mechanisms: via intracellular particles through cell junctions to neighboring
cells or via secreted virions to adjacent or remote cells. The observation of clusters of hepadnavirus-infected
cells both in vivo and in primary hepatocytes neither proves the first mechanism nor excludes the second. In
order to test which mechanism, if not both, is used by hepatitis B viruses in order to spread, we used primary
duck hepatocytes and duck hepatitis B virus (DHBV) as an infection model. If extracellular progeny virus alone
determines spreading, neutralizing antisera or drugs blocking virus binding to hepatocytes should abolish
secondary infection. In order to test this, we used DHBV envelope-specific neutralizing antisera, as well as
suramin, a known inhibitor of infection. Both reagents strongly reduced hepatocellular attachment of viral
particles and almost completely abolished primary infection, whereas an ongoing intracellular infection was
not affected as long as no progeny virus was released. In contrast, incubation of infected primary hepatocytes
with these reagents during release of progeny virus completely prevented secondary infection. Moreover, the
combination of electron and immunofluorescence microscopy analyses revealed the residence of viral particles
in cytoplasmic vesicles preferentially located near the basolateral membrane of infected hepatocytes. Taken
together, these data strongly suggest that hepatitis B viruses mainly spread by secreted, extracellular progeny
and point to polarized egress of viral particles into intercellular compartments, which restricts their diffusion
and favors transmission of virus to adjacent cells.
Hepadnaviruses, including the prototype human hepatitis B
virus (HBV), are small enveloped DNA viruses that predom-
inantly replicate in hepatocytes in a noncytotoxic manner.
Upon exposure of ducklings to duck HBV (DHBV) at a low
multiplicity of infection, virtually all hepatocytes in the liver
tissue are infected within a short time period (6). Given the
enormous size of the liver, with ca. 1011 hepatocytes, the mode
of viral spread must therefore be very efficient. In vivo, clusters
of virus-replicating cells are frequently observed during the
early phases of infection (5). Moreover, similar clusters are
also seen in primary hepatocyte cultures (unpublished data).
These seminal observations indirectly suggest that HBVs are
transmitted from cell to cell and may indicate that the infec-
tious movement of progeny virus in the extracellular environ-
ment is not controlled by diffusion alone. On the other hand, it
is well known that a large number of virions, as well as non-
infectious subviral particles lacking nucleocapsids, are secreted
from infected hepatocytes into the extracellular space, where
free diffusion should allow infection of remote host cells.
Alphaherpesviruses, human immunodeficiency viruses (HIV),
and poxviruses are able to move from an infected cell to an
adjoining uninfected cell by direct cell-to-cell spread (3, 13,
16). This transmission occurs specifically at sites of cell-cell
contact; herpesviruses, for example, move to neurons across
epithelial cells or neuronal junctions. This type of viral spread
is typically very rapid and efficient; this is not only due to the
close spatial proximity of virus and cellular determinants of
infection but may also be due to the protection of progeny
virus from neutralizing antibodies or other immune system
components by junctions. Other viruses exploit different modes
of spread that also proved to be very efficient. Vaccinia virus,
for example, spreads by at least two modes, one of which
protects the virus from neutralizing antibodies (suggesting di-
rect spread), whereas the other is antibody sensitive (suggest-
ing spread through extracellular virus) (9).
In the present study, we analyzed the mechanism of hepad-
naviral spread in vitro by using DHBV and primary duck hepa-
tocytes (PDHs) as a model system. To date, it is unknown
whether HBVs are transmitted directly from cell to cell or if
infection of neighboring cells requires progeny first to be re-
leased from the producer cell. In the latter case, virus infection
should be sensitive to neutralizing antibodies and drugs that
interfere with the binding of viral particles to their target cells.
By using two neutralizing antisera (2, 15) and suramin, a drug
known to abolish DHBV infection of hepatocytes (11), we
obtained evidence that infection of PDHs during the second
round is mainly, if not exclusively, achieved by progeny virus
secreted into the extracellular space. Furthermore, we provide
evidence that the egress of DHBV particles is polarized, which
may at least partially contribute to the preferential transmis-
sion of virus to adjacent cells.
MATERIALS AND METHODS
Primary hepatocyte cultures and cell lines. PDHs were prepared and culti-
vated as described elsewhere (14). Briefly, PDHs were prepared from livers of
fetal ducks by the collagenase digestion method. Liver cells were resuspended in
Williams’ medium E (Gibco-BRL) supplemented with 1.5% dimethyl sulfoxide,
1 nM insulin, and 10 M hydrocortisone (all from Sigma, Steinheim, Germany),
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2 mM glutamine, 15 mM HEPES (pH 7.2), 100 U of penicillin/ml, and 100 g of
streptomycin/ml and then seeded into 12-well plates at a density of ca. 5  105
liver cells per well. Persistently DHBV-replicating D2 cells were maintained in
Dulbecco’s modified Eagle’s medium containing 2 mM glutamine, sodium pyru-
vate, 100 U of penicillin/ml, 100 g of streptomycin/ml, and 10% fetal calf serum.
All cells were grown in a humidified 5% CO2-air atmosphere.
Viruses, antibodies, and drugs. PDHs were infected with a DHBV-viremic
goose serum containing 1.1  1010 genome equivalents (GE)/ml as determined
by dot blot analysis. Serum pools were divided into aliquots and stored at70°C.
For attachment and infection assays, we used two rabbit anti-DHBV preS-
specific sera (designated DPSI and KpnI), an unrelated control rabbit serum, and
immunopurified rabbit anti-mouse immunoglobulin G (IgG; Sigma). The DPSI
and KpnI antibodies were raised against recombinant DHBV L protein spanning
amino acids 1 to 131 and amino acids 44 to 185 of the preS domain, respectively
(4, 15). Suramin was purchased from Sigma, dissolved in dimethyl sulfoxide
(stock of 100 mg/ml) and stored at 20°C. For immunoblot and fluorescence
analyses, we used polyclonal rabbit anti-DHBV preS serum as described previ-
ously (14). Secondary, goat anti-rabbit antibodies conjugated with Alexa 488 or
horseradish peroxidase were obtained from Molecular Probes (Leiden, The
Netherlands) and Dianova (Hamburg, Germany), respectively.
Attachment and interference assay. To determine the amount of virions bound
to the cell surface of PDHs, cultures were first pretreated for 0.5 h with 100 g
of suramin/ml or were left untreated. They were then inoculated with viremic
goose serum corresponding to 220 GE per hepatocyte. Thereafter, cells were
transferred to 4°C for 2 h to allow virus binding but not uptake. After an
extensive washing with phosphate-buffered saline (PBS), the cells were harvested
by lysis in PCR sample buffer (8). To investigate the effect of neutralizing
antibodies on viral attachment, the inoculum was preincubated with 10 l of the
antisera DPSI, KpnI, control rabbit serum, or 20 g of purified IgG for 0.5 h at
37°C and then added to the cells. Cultures were incubated for 2 h at 4°C before
they were extensively washed with PBS and harvested in 200 l of PCR sample
buffer. For analysis of the GE dependency of viral attachment, PDHs were
inoculated with different amounts of viremic serum corresponding to 2, 22, 110,
and 220 GE/cell; the PDHs were then incubated and harvested as described
above.
Detection of viral DNA by PCR. Each sample was digested for 2 h at 56°C with
proteinase K (Roche, Mannheim, Germany); the enzyme was then inactivated
for 10 min at 95°C, and the sample was subjected to PCR with DHBV-specific
primers as described previously (8). For semiquantitative PCR analysis, 10-fold
serial dilutions of a viremic serum with known GE were included in each PCR
run.
Inhibition of primary infection. To investigate the effects of the antisera and
suramin on primary infection, viremic serum was preincubated with the same
amount of antisera as described above or the cells were pretreated with suramin
(pretreatment) before inoculation of cells. Alternatively, 100 g of suramin or 10
l of DPSI antiserum/ml was added to the cells along with the inoculum (syn-
chronous treatment) or after 2 h (posttreatment). Subsequently, cells were in-
cubated overnight at 37°C, and thereafter unbound viral particles were removed
by washing the cells. Bound, not-yet-internalized virions were inactivated by a
low-pH shock (8). The cells were further incubated for 3 days before harvest and
then analyzed for preS protein by immunostaining and blotting.
Inhibition of secondary infection and viral spread. PDHs were infected with
220 GE/cell overnight; medium was then changed, and 3 days later the cells were
incubated with either 100 g of suramin or 10 l of antiserum DPSI/ml. At this
time point, the infected cells start to secrete progeny virus. The medium was
renewed daily, and fresh substances were added. Three days later, cells were
fixed and stained as described below.
Effect of suramin and neutralizing preS antisera on ongoing viral replication.
To assay the effect of antisera and suramin on viral replication and secretion, the
persistently DHBV-propagating LMH cell line D2 was incubated continuously
for 3 days with the same amount of suramin and preS antiserum as used for the
inhibition of secondary infection, and then cell culture supernatants and cells
were harvested and subjected to PCR or immunoblot analysis of viral DNA or
preS protein, respectively.
Confocal laser scanning microscopy. PDHs grown on coverslips were infected
with DHBV; 1 week later they were fixed and stained for preS. Pictures were
acquired with a scanning confocal microscope (LSM 510 META; Zeiss, Berlin,
Germany) and processed by using the Openlab software.
Electron microscopy. Chronically infected PDHs were fixed with 2.5% glutar-
aldehyde in PBS for 20 min at room temperature, washed, and postfixed for 30
min with 1% OsO4 in PBS. For ultrathin sectioning, the samples were gradually
dehydrated with ethanol and embedded in ERL resin. Sections were counter-
stained with 2% uranyl acetate and lead citrate. The electron micrographs were
obtained with a Philips CM 120 transmission electron microscope at 60 kV.
Immunofluorescence microscopy. Cultures were washed once with PBS and
fixed with an ice-cold mixture of methanol-acetone (1:1) for 10 min at room
temperature. Cells were rehydrated with PBS and then incubated for 1 h with
rabbit anti-DHBV preS serum KpnI diluted 1:800. Cells were then washed three
times with PBS and incubated with secondary goat anti-rabbit Alexa 488-labeled
(green) antibody (diluted 1:800) for another 30 min. Nuclei were counterstained
with Hoechst (final concentration, 4 g/ml). After they were mounted and
embedded, stained cells were analyzed and photographed exactly as described
previously (14).
SDS-PAGE and immunoblotting. Cells grown in 12-well culture plates were
washed with PBS and directly lysed in 200 l of 4 Laemmli buffer per well. All
samples were boiled at 99°C for 5 min, and 20 l of each sample was fractionated
by denaturating sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE). Subsequently, proteins were transferred onto nitrocellulose mem-
branes. After they were blocked with 3% dry milk diluted in Tris-buffered saline
(TBS; 50 mM Tris-HCl, 150 mM NaCl), the membranes were incubated for 1 h
at room temperature with rabbit anti-DHBV preS antiserum KpnI (diluted
1:20,000). After several washes with TBS plus 0.1% Tween 20, membranes were
further incubated with horseradish peroxidase-coupled goat anti-rabbit IgG an-
tibodies at a dilution of 1:20,000. Proteins were visualized by enhanced indirect
chemiluminescence (Pierce).
RESULTS AND DISCUSSION
The spread of viruses via extracellular progeny is sensitive to
neutralizing antibodies or substances that interfere with the
initial steps of virus-cell interaction (9). In order to identify
substances that specifically prevent the attachment of DHBV
particles to hepatocytes that are required to elucidate the
spreading mode of DHBV, we tested the effect of suramin and
two different preS-directed antisera on the attachment of
DHBV to PDHs. Suramin was previously reported to prevent
DHBV infection of hepatocytes by interference with an as-yet-
unspecified early infection step (11, 12). Since suramin pre-
vents binding of HIV and herpesviruses to host cells (1, 17), we
assumed that the same applies to DHBV. The preS domain of
the L protein has been shown to mediate interaction of DHBV
to hepatocytes, and antibodies binding to this domain are ex-
pected to neutralize virus infection by interference with attach-
ment of virions to host cells. To test this experimentally, we
used two independent DHBV L-specific antisera directed
against the preS domain (DPSI and KpnI; see Materials and
Methods) in our attachment interference assay. As a specificity
control for the anti-preS antibodies, we used immunopurified
mouse anti-rabbit IgG and unrelated rabbit antiserum.
To determine the effect of suramin and the preS-specific
antisera on attachment of DHBV to hepatocytes, cells were
pretreated for 0.5 h with 100 g of suramin/ml or viremic
serum preincubated with anti-preS sera or control sera prior to
inoculation of the cells at 4°C for 2 h. The experimental con-
ditions used allow only virus binding to but not uptake into the
hepatocytes. Subsequently, cells were washed and harvested,
and the amounts of cell-associated viral DNA were determined
after agarose gel electrophoresis of amplified PCR products.
Tenfold serial dilutions of a DHBV viremic serum with known
GE were included to calibrate the PCR (Fig. 1A, lanes 11 to
14). These experiments revealed an assay sensitivity of 104
GE and linearity between 104 and 106 GE. The amount of
attached virions proportionally increased with more GE per
cell used (2 to 220) (Fig. 1A, lanes 1 to 5). The two neutralizing
anti-preS antibodies used strongly inhibited the attachment of
virions to PDHs (Fig. 1A, lanes 5 to 7). This was specific since
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the preincubation of inoculum with nonspecific IgG or control
rabbit serum (Fig. 1A, lanes 5, 9, and 10) had no effect.
Suramin reduced binding of DNA-containing particles to
hepatocytes to an extent similar to that of the neutralizing
antibodies (Fig. 1A, lanes 5 to 8), indicating that the antiviral
effect of suramin is mainly due to its interference with virus
attachment. In order to correlate the results obtained from the
attachment interference assays with productive infection,
treated cultures were incubated for 3 days and stained for preS
as an indicator for successful infection. It was obvious that the
reduced binding resulted in a dramatically reduced number of
infected cells in both the anti-preS serum-treated and the
suramin-treated cultures (Fig. 1B). In contrast, the unrelated
antiserum that did not reduce viral binding also had no influ-
ence on infection efficiency (Fig. 1B, unrelated antibody).
Taken together, these findings imply that most of the virus
binding measured under our experimental conditions is spe-
cific and relevant for productive infection.
In order to determine any possible effects of suramin or the
anti-preS sera postattachment, we investigated whether preS
antiserum and suramin affect productive primary infection
when given simultaneously or after virus attachment and, as a
further control, also when given before attachment. DHBV
viremic serum and PDHs were preincubated with the antibody
and suramin, respectively, and then the inocula were added to
the cells. Alternatively, suramin and DPSI antibody were
added to the cells together with the inoculum or 2 h later.
Expression of preS protein was measured 3 days later and used
as an indicator for productive infection. Immunoblot analysis
of the cellular lysates showed that suramin and anti-preS se-
rum DPSI strongly reduced infection when they were admin-
istered prior to or concomitantly with virus to the cells (Fig.
2A, lanes 2, 3, 4, 6, and 7). The addition of antibody or drug 2 h
after exposure of the cells to virus had no effect on the effi-
ciency of productive DHBV infection compared to untreated
cells (Fig. 2A, lanes 2, 5, and 8). Taken together, both reagents
FIG. 1. (A, upper panel) Hepatocellular attachment of DHBV increases with larger amounts of GE. To analyze the GE dependency of virus
binding to hepatocytes, cells were incubated with DHBV at different GE levels for 2 h at 4°C, washed, harvested, and subjected to DHBV
DNA-specific PCR. (A, lower panel) preS-specific antisera DPSI and KpnI, as well as suramin, impair viral attachment to hepatocytes. DHBV
viremic serum or cells were preincubated for 0.5 h at 37°C with the indicated antisera or suramin, respectively. Subsequently, the cultures were
inoculated and shifted to 4°C for 2 h to allow virus binding to cells. Cultures were then washed to remove unbound viral particles and then
harvested. Next, the amount of cell-associated viral DNA was determined after agarose gel electrophoresis of amplified PCR products. Tenfold
serial dilutions of a DHBV viremic serum with a known GE level were included to calibrate the PCR. Sur., suramin; RS, nonspecific control rabbit
serum. (B) Diminished virion binding leads to reduced infection. Cultures treated and inoculated as described above were further cultivated for
3 days, fixed, and immunostained for preS protein, indicating successful viral infection. Nuclei were counterstained with Hoechst.
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have no detectable postattachment effects on primary infection
and thus are optimally suited for deciphering the mechanisms
of hepadnaviral spreading. Suramin strongly inhibits attach-
ment and subsequent infection, presumably by preventing viral
interaction with the cell surface, whereas the preS antibody
DPSI binds to the preS segment of the envelope protein L and
thereby renders the viral particles incompetent for binding to
hepatocytes. Analysis of the treated and nontreated primary
hepatocytes immunostained for preS (Fig. 2B) largely con-
firmed the results obtained by immunoblotting of the corre-
sponding cell extracts. Very few infected cells were observed
among cells pretreated or concomitantly incubated with
suramin, whereas no infected cells were observed in cultures
pretreated or concomitantly incubated with DPSI antibody
(Fig. 2B, DPSI and suramin). Notably, suramin was slightly less
efficient than the preS antiserum in its neutralizing activity to
prevent productive infection.
Since preS-specific antibodies and suramin strongly reduced
attachment of viral particles and led to a virtually complete
abolition of productive DHBV infection in PDHs, they should
strongly inhibit viral spread by blocking the second round of
infection, provided the extracellular progeny virus alone deter-
mines the extent and pattern of viral spread. To test this, we
first infected PDHs and incubated them 3 days later with
suramin or the preS antisera. At this time point postinfection,
productive DHBV infection was established in the hepato-
cytes, and the first progeny virions started to be released.
Three days after the start of treatment, cells were immuno-
stained for preS protein. Immunostaining of infected, un-
treated PDH cultures for preS revealed that infected cells were
not randomly distributed throughout the culture but appeared
in clusters of infected cells (Fig. 3). In each of these clusters,
one or a few cells were stained prominently (Fig. 3B), sur-
rounded by less strongly labeled cells. The brightly stained cells
presumably correspond to the primarily infected ones from
which the neighboring cells were infected thereafter. Consis-
tent with this speculation, treatment with neutralizing antibod-
ies prevented this cluster formation: mainly single brightly
stained cells could be seen, indicating that progeny virus pro-
duced by the primarily infected cells was neutralized by the
preS antibody and thereby lost its ability to infect neighboring
hepatocytes. Suramin treatment also abolished the formation
of clusters of DHBV-infected cells with similar efficiency, im-
plying that released progeny virus needs to bind to the cell
surface of adjoining cells for successful infectious entry.
In order to exclude the possibility that the reagents used
prevented viral spread not by neutralizing free virions but by
acting on intracellular viral replication or impairing release of
progeny, we treated the persistently DHBV-producing LMH
cell line D2 continuously with suramin or with neutralizing
preS antisera for 3 days. Subsequently, cell culture superna-
tants and cells were harvested and analyzed for viral DNA or
FIG. 2. Productive infection is diminished in antibody- or suramin-treated cells when they are treated prior to infection or simultaneously with
inoculation. (A) preS immunoblot analysis of cell lysates. PDHs and inoculum were either pretreated or preincubated with suramin or antiserum
DPSI, respectively (pre), or the substances were given along with the inoculum (syn) or postinoculation (post). Three days after infection, the cells
were harvested in Laemmli buffer and subjected to denaturating SDS-PAGE. Arrows point to the p36 and p28 form of the DHBV L protein.
(B) Corresponding immunofluorescence staining of cells treated as described in panel A. Cells were fixed and immunostained for preS protein
expression (preS), and nuclei were counterstained with Hoechst.
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preS protein, respectively. No effects on viral secretion (Fig.
4A) or on preS expression (Fig. 4B) were observed, arguing
against an effect of these reagents on virus progeny production
or release. Analogous experiments performed with naturally
infected PDHs also showed no significant changes in the in-
tracellular steady-state levels of viral preS and core protein nor
in the cellular protein amount of actin compared to untreated
controls (data not shown). Consistent with these results are the
data obtained from a cell viability assay with fluorescein diac-
etate (FDA), an established and sensitive assay for testing the
functionality of hepatocyte cultures. After its active uptake,
FDA is metabolized and deacetylated. The deacetylated form
is fluorescent and can be easily visualized by fluorescence mi-
croscopy. Treatment of cultures for 3 days with suramin influ-
enced neither the morphology, the viability, nor the function-
ality of the hepatocytes. Taken together, these control
experiments indicate that suramin interferes with neither the
late steps of DHBV replication nor the cellular metabolism of
PDHs (data not shown). The observation mentioned above
that the treatment of PDHs 2 h after primary infection does
not lead to reduced preS levels when measured 3 days there-
after also strongly argues against unspecific effects of both
reagents (suramin and preS antisera) on an established infec-
tion.
Taken together, these data indicate that the hepadnavirus
must first be released from the primarily infected cell and then
must bind to the surface of uninfected, adjacent cells for the
successful transmission of virus infection. In summary, our
data strongly suggest that spread of DHBV during second
FIG. 3. Neutralizing antibodies and suramin inhibit the spread of DHBV in vitro. PDHs were infected with DHBV. Three days later, suramin
or preS antibody DPSI was added to the medium to inhibit the spread mediated by released virions from primarily infected to adjacent cells. The
medium was changed daily, and new substances were added. After 3 more days, cells were fixed and stained for preS protein. (A) Lower
magnification of the cells showing an overview of the field; (B) higher magnification showing the clusters of infected cells.
FIG. 4. preS antibodies and suramin do not impair viral secretion
or replication. (A and B) Persistently DHBV replicating D2 cells were
continuously treated with the preS-specific KpnI antibody or suramin
for 3 days. Thereafter, cell culture supernatants and cells were har-
vested. (A) Analysis of viral DNA in supernatants by PCR. Portions (5
l) of the supernatants were dissolved in PCR sample buffer and
subjected to DHBV DNA-specific PCR. Amplified products were vi-
sualized on an ethidium bromide-stained agarose gel after electro-
phoresis. (B) Analysis of intracellular steady-state levels of preS pro-
tein by immunoblotting. Treated cells were lysed in Laemmli buffer
and subjected to immunoblot for preS. Arrows point to bands corre-
sponding to the p36 and p28 species of L protein.
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FIG. 5. Electron and confocal microscopic view of intracellular distribution of viral particles in PDHs. (A) Chronically infected PDHs were
fixed and processed for electron microscopy 7 days after seeding. A detailed view of the cytoplasmic area of an infected cell is shown. It shows two
individual vesicles (arrows) containing virions (solid arrowheads) and numerous subviral particles (open arrowheads). ES, extracellular space; CM,
cytoplasmic membrane; mito, mitochondrion. (B) Confocal microscopic analysis of the cellular distribution of L protein in PDHs. Cells grown on
coverslips were infected with DHBV, fixed 7 days later, and immunostained for viral L protein and analyzed by confocal laser scanning microscopy.
Selected successive sections of the same group of cells (1 to 6, from top to bottom) are shown. The arrowheads indicate cytoplasmic membrane
staining; the arrows point to particle-laden vesicles in the hepatocytes.
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round of infection requires the release of progeny virus into
the extracellular space.
The question remained as to why clusters of infected hepa-
tocytes were observed. This should not be the case if spreading
does not occur via cell junctions but is only mediated by prog-
eny viruses eventually released at many random places all
along the cellular membrane, from where they can then diffuse
or be swept away unhindered into the extracellular environ-
ment. A possible explanation for this phenomenon may be that
the cluster formation seen in early infection of the cell cultures
is due to the polarized egress of virions into intercellular com-
partments. These putative compartments may hinder the virus
from diffusing freely upon secretion. If correct, this assumption
would imply that progeny virus is not secreted at random sites
along the cell surface but is released preferentially at specific
regions. This is certainly conceivable because polarized egress
has been recently reported for other viruses, including HIV
(for a review, see reference 7), and hepatocytes are well known
for their highly polarized organization, including sorting of
exocytic vesicles (10, 18). In order to get a first hint as to
whether the release of hepadnaviruses occurs by polarized
egress, electron microscopic and immunofluorescence staining
studies were performed. The ultrastructural analysis of
DHBV-infected PDHs by electron microscopy revealed that
virions (Fig. 5A, solid arrowheads) and subviral particles (Fig.
5A, open arrowheads) were grouped together in membrane-
surrounded cytoplasmic vesicles (Fig. 5A, arrows). In fact, we
observed no single free viral particle in the cytoplasm which, if
present, should theoretically be transportable much faster than
the observed vesicles via cell junctions to neighboring cells.
PreS-immunostaining of infected cells showed a punctate pat-
tern consistent with the electron microscopic finding and fur-
ther indicating that preformed viral particles are subcompart-
mentalized in vesicular structures in the cytoplasm (Fig. 5B,
arrows). Scanning a small colony of infected hepatocytes in
horizontal planes of about 0.3-m thickness by confocal laser
scanning microscopy revealed that preS-containing cellular
vesicles are not randomly distributed throughout the cytoplasm
but preferentially accumulate at the basolateral sites of the
cytoplasmic membrane (Fig. 5B). Notably, a prominent stain-
ing of the cellular membrane was visible (Fig. 5B, arrowheads).
The virus particle-carrying vesicles are presumably transported
toward the cellular membrane for release of their cargo and
are therefore preferentially found near the cytoplasmic mem-
brane of the infected hepatocyte. Although some particles
were found near the apical membrane, most were located near
the basolateral membrane. When these viral particle-laden
vesicles fuse with the plasma membrane, viruses and subviral
particles would be released concomitantly and directed into
the basolaterally located intercellular space. This may well
hamper free diffusion and promote preferential formation of
clusters of infected cells.
Taken together, our data strongly suggest that hepadnavi-
ruses mainly or exclusively spread via extracellular progeny to
adjacent cells through polarized egress into intercellular com-
partments. Insights into the spreading mode of hepadnaviruses
and the identification of substances that prevent the viral
spread may provide additional opportunities to develop ur-
gently needed new strategies that allow efficient treatment of
chronic hepatitis B infection.
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